Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Incyte, The University of Kentucky Research Foundation, PE Corporation/Applera

Premium

Affymetrix has received US Patent Number 6,420,169, “Apparatus for forming polynucleotides or polypeptides.” The patent covers a method for in situ synthesis of oligonucleodides, first by irradiating a predefined region of the substrate to deprotect the substrate. A nucleotide is then added to the substrate in the irradiated region, and is coupled to it. These steps are repeated in order to create an array of oligonucleotides.

 

Incyte has been awarded US Patent Number 6,420,114, “Microarray hybridization chamber.” The patent describes a chamber for mixing a film of fluid, and a method for mixing the fluid by creating a bubble and moving the bubble around in the fluid.

 

The University of Kentucky Research Foundation in Lexington, Ky., has received US Patent Number 6,420,105, “Method for analyzing molecular expression or function in an intact single cell.” The patent covers a technique in which the molecular contents of an intact cell can be detected. The method involves isolating the cell from its organ tissue by subjecting the tissue to a dissociation method, and collecting it with a device that can ensure it remains intact; withdrawing device, then isolating the molecules in the single cell.

 

PE Corporation, now Applera, has been awarded US Patent Number 6,416,990, “Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof.” The patent describes amino acid sequences of kinase peptides, and the peptide molecules, as well as the nucleic acid molecules that encode them. It also provides methods of identifying orthologous and paralogous molecules, as well as modulators of the peptides.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.